# Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease

> **NCT07839871** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 920 (estimated)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** RSVpreF
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07839871
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-28
- **Primary completion:** 2031-04-01
- **Final completion:** 2031-04-01
- **Target enrollment:** 920 (ESTIMATED)
- **Last updated:** 2026-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07839871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07839871, "Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV Disease". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07839871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
